U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07340372) titled 'Home Monitoring in eAMD Treatment' on Jan. 06.
Brief Summary: The goal of this observational clinical study is to collect more information about the efficacy of Aflibercept 8 mg injections in people with eAMD. The main questions it aims to answer are:
* To reassure patients and doctors with longer intervals using home monitoring app;
* To assess patient reported outcomes (PROMs) and Value-based Healthcare.
Participants already taking Aflibercept 8 mg as part of their regular medical care for eAMD will undergo regular ophthalmological examination and use a home monitoring app, in a one year and a two-year treatment period.
Study ...